BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysacc…
Biotechnology
US, San Rafael [HQ]
Balance Sheet
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 917.00 | 1,262.00 | 1,303.00 | 1,601.00 | 2,249.00 | 2,490.00 | 3,729.00 | 4,023.00 | 4,633.00 | 4,427.00 | 4,690.00 | 5,848.00 | 6,003.00 | 6,375.00 | 6,841.00 | |
|
Current
|
467.00 | 504.00 | 469.00 | 743.00 | 1,137.00 | 1,425.00 | 1,089.00 | 1,421.00 | 2,207.00 | 2,056.00 | 1,942.00 | 2,342.00 | 2,274.00 | 2,751.00 | 2,956.00 | |
| Cash And Equivalents | 167.00 | 88.00 | 46.00 | 180.00 | 568.00 | 875.00 | 397.00 | 408.00 | 598.00 | 493.00 | 437.00 | 649.00 | 587.00 | 724.00 | 755.00 | |
| Assets | 917.00 | 1,262.00 | 1,303.00 | 1,601.00 | 2,249.00 | 2,490.00 | 3,729.00 | 4,023.00 | 4,633.00 | 4,427.00 | 4,690.00 | 5,848.00 | 6,003.00 | 6,375.00 | 6,841.00 | |
| Accounts Receivables (AR) | -19.00 | -13.00 | -18.00 | -4.00 | -8.00 | -26.00 | -16.00 | -51.00 | -25.00 | -54.00 | -37.00 | -59.00 | 65.00 | -82.00 | -190.00 | |
| Inventory | 78.00 | 109.00 | 130.00 | 128.00 | 162.00 | 199.00 | 271.00 | 355.00 | 475.00 | 530.00 | 680.00 | 698.00 | 776.00 | 894.00 | 1,107.00 | |
| Short Term Investments | 133.00 | 186.00 | 148.00 | 270.00 | 215.00 | 69.00 | 195.00 | 381.00 | 797.00 | 590.00 | 316.00 | 416.00 | 426.00 | 567.00 | 318.00 | |
| Other Current Assets | 14.00 | 33.00 | 39.00 | 25.00 | 41.00 | 105.00 | 60.00 | 61.00 | 74.00 | 98.00 | 130.00 | 129.00 | 110.00 | 104.00 | 141.00 | |
|
Non Current
|
449.00 | 758.00 | 833.00 | 858.00 | 1,111.00 | 1,064.00 | 2,639.00 | 2,601.00 | 2,425.00 | 2,370.00 | 2,747.00 | 3,505.00 | 3,728.00 | 3,623.00 | 3,885.00 | |
| Property, Plant, Equipment (Net) | 199.00 | 221.00 | 268.00 | 284.00 | 319.00 | 523.00 | 704.00 | 798.00 | 896.00 | 948.00 | 1,010.00 | 1,032.00 | 1,035.00 | 1,073.00 | 1,112.00 | |
|
Intangible Assets
|
40.00 | 103.00 | 180.00 | 162.00 | 163.00 | 156.00 | 683.00 | 553.00 | 517.00 | 491.00 | 456.00 | 417.00 | 388.00 | 338.00 | 294.00 | |
| Goodwill | 23.00 | 53.00 | 51.00 | 51.00 | 54.00 | 54.00 | 197.00 | 197.00 | 197.00 | 197.00 | 197.00 | 196.00 | 196.00 | 196.00 | 196.00 | |
| Long Term Investments | 170.00 | 129.00 | 94.00 | 117.00 | 281.00 | 98.00 | 425.00 | 572.00 | 385.00 | 235.00 | 411.00 | 285.00 | 507.00 | 333.00 | 615.00 | |
| Other Non Current Assets | 15.00 | 14.00 | 15.00 | 16.00 | 143.00 | 65.00 | 408.00 | 32.00 | 29.00 | 36.00 | 122.00 | 142.00 | 151.00 | 176.00 | 121.00 | |
| Liabilities | 594.00 | 545.00 | 530.00 | 585.00 | 908.00 | 962.00 | 1,328.00 | 1,257.00 | 1,824.00 | 1,459.00 | 1,567.00 | 1,742.00 | 1,732.00 | 1,771.00 | 1,890.00 | |
|
Current
|
78.00 | 83.00 | 94.00 | 170.00 | 183.00 | 235.00 | 445.00 | 439.00 | 816.00 | 523.00 | 932.00 | 492.00 | 539.00 | 588.00 | 1,177.00 | |
| Accounts Payable | 8.00 | 5.00 | 12.00 | 33.00 | 8.00 | 36.00 | 116.00 | -33.00 | 24.00 | 20.00 | 50.00 | -68.00 | 15,689.00 | 59.00 | 68.00 | |
| Short Term Debt | - - | 75.00 | - - | 23.00 | - - | - - | - - | 22.00 | 360.00 | - - | 361.00 | 11.00 | 10.00 | 10.00 | 502.00 | |
| Deferred Revenue | - - | - - | - - | -77.00 | - - | - - | - - | - - | - - | - - | 13.00 | - - | 6.00 | - - | 4.00 | |
| Tax Payable | - - | 3.00 | 3.00 | 2.00 | 3.00 | 5.00 | 65.00 | 7.00 | 15.00 | 7.00 | 8.00 | 19.00 | 3.00 | 16.00 | 2.00 | |
| Other Current Liabilities | 78.00 | 3.00 | 81.00 | 77.00 | 87.00 | - - | 52.00 | 46.00 | 53.00 | 85.00 | -13.00 | 289.00 | 329.00 | 346.00 | 354.00 | |
|
Non Current
|
516.00 | 461.00 | 436.00 | 415.00 | 724.00 | 726.00 | 883.00 | 818.00 | 1,007.00 | 935.00 | 635.00 | 1,249.00 | 1,192.00 | 1,183.00 | 713.00 | |
| Long Term Debt | 497.00 | 377.00 | 348.00 | 324.00 | 655.00 | 657.00 | 662.00 | 660.00 | 813.00 | 830.00 | 486.00 | 1,075.00 | 1,079.00 | 1,083.00 | 593.00 | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 10.00 | 11.00 | 10.00 | 10.00 | 38.00 | |
| Deferred Non Current Tax Liabilities | - - | 36.00 | 35.00 | 33.00 | 150.00 | 166.00 | 143.00 | - - | 44.00 | 62.00 | - - | - - | - - | - - | - - | |
| Other Non Current Liabilities | 19.00 | 46.00 | 52.00 | 26.00 | 38.00 | 30.00 | 44.00 | 157.00 | 150.00 | 105.00 | 148.00 | 174.00 | 113.00 | 100.00 | 119.00 | |
| Equity | 322.00 | 717.00 | 773.00 | 1,015.00 | 1,341.00 | 1,527.00 | 2,400.00 | 2,766.00 | 2,808.00 | 2,967.00 | 3,122.00 | 4,106.00 | 4,270.00 | 4,603.00 | 4,951.00 | |
| Stockholders' Equity | 322.00 | 717.00 | 773.00 | 1,015.00 | 1,341.00 | 1,527.00 | 2,400.00 | 2,766.00 | 2,808.00 | 2,967.00 | 3,122.00 | 4,106.00 | 4,270.00 | 4,603.00 | 4,951.00 | |
| Retained Earnings | -577.00 | -371.00 | -425.00 | -539.00 | -715.00 | -849.00 | -1,021.00 | -1,520.00 | -1,637.00 | -1,694.00 | -1,720.00 | -861.00 | -925.00 | -789.00 | -621.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Profit | - - | 205.00 | -53.00 | -114.00 | -176.00 | -133.00 | -171.00 | -630.00 | -117.00 | -77.00 | -23.00 | 854.00 | -64.00 | 141.00 | 167.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 898.00 | 1,088.00 | 1,193.00 | 1,555.00 | 2,051.00 | 2,350.00 | 3,401.00 | 4,273.00 | 4,468.00 | 4,656.00 | 4,822.00 | 4,983.00 | 5,181.00 | 5,396.00 | 5,611.00 | |
| Loss Other Compr. Income | - - | - - | 4.00 | - - | 5.00 | 27.00 | 21.00 | 12.00 | -22.00 | 5.00 | 20.00 | -16.00 | 14.00 | -3.00 | -38.00 |